(Q33850688)

29 July 2017

1 reference

title

The immunopathogenesis of Miller Fisher syndrome (English)

1 reference

29 July 2017

main subject

Miller Fisher syndrome

1 reference

Willison HJ

1

1 reference

29 July 2017

O'Hanlon GM

series ordinal

2

1 reference

29 July 2017

publication date

1 December 1999

1 reference

Journal of Neuroimmunology

29 July 2017

published in

1 reference

29 July 2017

volume

100

1 reference

29 July 2017

issue

1-2

1 reference

29 July 2017

page(s)

3-12

1 reference

Ataxic polyneuropathy and anti-Pr2 IgM kappa M proteinemia

29 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900213-1

7 January 2021

Lipopolysaccharides of Campylobacter jejuni serotype O:19: structures of core oligosaccharide regions from the serostrain and two bacterial isolates from patients with the Guillain-Barré syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900213-1

7 January 2021

Immunoglobulin G from a patient with Miller-Fisher syndrome rapidly and reversibly depresses evoked quantal release at the neuromuscular junction of mice.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900213-1

7 January 2021

Neuromuscular blockade by IgG antibodies from patients with Guillain-Barré syndrome: a macro-patch-clamp study

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900213-1

7 January 2021

Pre- and postsynaptic blockade of neuromuscular transmission by Miller-Fisher syndrome IgG at mouse motor nerve terminals

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900213-1

7 January 2021

Lipid composition of neuronal cell bodies and neurites from cultured dorsal root ganglia

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900213-1

7 January 2021

Clinical correlate and fine specificity of anti-GQ1b antibodies in peripheral neuropathy

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900213-1

7 January 2021

Serum IgG antibody to ganglioside GQ1b is a possible marker of Miller Fisher syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900213-1

7 January 2021

Serum anti-GQ1b IgG antibody is associated with ophthalmoplegia in Miller Fisher syndrome and Guillain-Barré syndrome: clinical and immunohistochemical studies

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900213-1

7 January 2021

Ganglioside composition of the human cranial nerves, with special reference to pathophysiology of Miller Fisher syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900213-1

7 January 2021

Brainstem involvement in a child with ophthalmoplegia, ataxia, areflexia syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900213-1

7 January 2021

An Unusual Variant of Acute Idiopathic Polyneuritis (Syndrome of Ophthalmoplegia, Ataxia and Areflexia)

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900213-1

7 January 2021

Differential expression of gangliosides on the surfaces of myelinated nerve fibers

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900213-1

7 January 2021

Abnormal evoked potentials in Miller-Fisher syndrome: further evidence of combined peripheral and central demyelination

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900213-1

7 January 2021

Monoclonal antibodies raised against Guillain-Barré syndrome-associated Campylobacter jejuni lipopolysaccharides react with neuronal gangliosides and paralyze muscle-nerve preparations.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900213-1

7 January 2021

Guillain-Barré syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900213-1

7 January 2021

Rabbit experimental sensory ataxic neuropathy: anti-GD1b antibody-mediated trkC downregulation of dorsal root ganglia neurons

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900213-1

7 January 2021

Motor nerve terminal degeneration provides a potential mechanism for rapid recovery in acute motor axonal neuropathy after Campylobacter infection.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900213-1

7 January 2021

Clinical and epidemiologic features of Guillain-Barré syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900213-1

7 January 2021

Monoclonal IgM in a patient with paraproteinemic polyneuropathy binds to gangliosides containing disialosyl groups

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900213-1

7 January 2021

Antibodies to GT1a ganglioside in patients with Guillain-Barré syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900213-1

7 January 2021

Serum anti-GQ1b IgG antibodies recognize surface epitopes on Campylobacter jejuni from patients with Miller Fisher syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900213-1

7 January 2021

Humoral immune response against Campylobacter jejuni lipopolysaccharides in Guillain-Barré and Miller Fisher syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900213-1

7 January 2021

Cross-reactive antibodies against gangliosides and Campylobacter jejuni lipopolysaccharides in patients with Guillain-Barré or Miller Fisher syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900213-1

7 January 2021

IgG anti-GT1a antibodies which do not cross react with GQ1b ganglioside in a pharyngeal-cervical-brachial variant of Guillain-Barré syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900213-1

7 January 2021

Bickerstaff's brainstem encephalitis associated with IgG anti-GQ1b antibody subsequent to Mycoplasma pneumoniae infection: favorable response to immunoadsorption therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900213-1

7 January 2021

Is IgG anti-GT1a antibody associated with pharyngeal-cervical-brachial weakness or oropharyngeal palsy in Guillain-Barré syndrome?

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900213-1

7 January 2021

Close association of IgA anti-ganglioside antibodies with antecedent Campylobacter jejuni infection in Guillain-Barré and Fisher's syndromes

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900213-1

7 January 2021

Selective staining of the cerebellar molecular layer by serum IgG in Miller-Fisher and related syndromes

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900213-1

7 January 2021

Ganglioside GT1b as a complementary receptor component for Clostridium botulinum neurotoxins

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900213-1

7 January 2021

Factors defining target specificity in antibody-mediated neuropathy: density-dependent binding of anti-GD1a polyclonal IgG from a neurological patient

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900213-1

7 January 2021

Generation of a monoclonal antibody specific for a new class of minor ganglioside antigens, GQ1b alpha and GT1a alpha: its binding to dorsal and lateral horn of human thoracic cord

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900213-1

7 January 2021

Localization of GM1 and GD1b antigens in the human peripheral nervous system

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900213-1

7 January 2021

Experimental sensory neuropathy induced by sensitization with ganglioside GD1b

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900213-1

7 January 2021

Binding of antibodies against GM1 and GD1b in human peripheral nerve.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900213-1

7 January 2021

Monospecific anti-GD1b IgG is required to induce rabbit ataxic neuropathy

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900213-1

7 January 2021

Special sensory ataxia in Miller Fisher syndrome detected by postural body sway analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900213-1

7 January 2021

A monoclonal antibody that recognizes ganglioside GD1b in the rat central nervous system

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900213-1

7 January 2021

Immunological parameters in Guillain-Barré syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900213-1

7 January 2021

Anti-GQ1b IgG antibody activities related to the severity of Miller Fisher syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900213-1

7 January 2021

Two species of antiganglioside antibodies in a patient with a pharyngeal-cervical-brachial variant of Guillain-Barré syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900213-1

7 January 2021

Monosialoganglioside (GM1) immunofluorescence in rat spinal roots studied with a monoclonal antibody

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900213-1

7 January 2021

Ganglioside GM1 binds to the Trk protein and regulates receptor function

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900213-1

7 January 2021

Neuro-ophthalmic manifestations of the syndrome of ophthalmoplegia, ataxia and areflexia. Observations on 20 patients

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900213-1

7 January 2021

Serum antibodies against gangliosides and Campylobacter jejuni lipopolysaccharides in Miller Fisher syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900213-1

7 January 2021

Anti-GM1 ganglioside antibodies cloned from autoimmune neuropathy patients show diverse binding patterns in the rodent nervous system

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900213-1

7 January 2021

Mapping immunoreactive epitopes in the human peripheral nervous system using human monoclonal anti-GM1 ganglioside antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900213-1

7 January 2021

Acute oropharyngeal palsy is associated with antibodies to GQ1b and GT1a gangliosides

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900213-1

7 January 2021

Autoimmune ataxic neuropathies (sensory ganglionopathies).

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900213-1

7 January 2021

IgM M-protein in a patient with sensory-dominant neuropathy binds preferentially to polysialogangliosides

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900213-1

7 January 2021

Anti-B-series ganglioside-recognizing autoantibodies in an acute sensory neuropathy patient cause cell death of rat dorsal root ganglion neurons

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900213-1

7 January 2021

Anti-ganglioside antibodies can bind peripheral nerve nodes of Ranvier and activate the complement cascade without inducing acute conduction block in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900213-1

7 January 2021

Diversity of lipopolysaccharide structures in Campylobacter jejuni

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900213-1

7 January 2021

Multifocal motor neuropathy: serum IgM binding to a GM1 ganglioside-containing lipid mixture but not to GM1 alone

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900213-1

7 January 2021

Miller Fisher anti-GQ1b antibodies: alpha-latrotoxin-like effects on motor end plates

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900213-1

7 January 2021

Serum factor in Miller-Fisher variant of Guillain-Barré syndrome and neurotransmitter release

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900213-1

7 January 2021

Miller-Fisher syndrome associated with Campylobacter jejuni bearing lipopolysaccharide molecules that mimic human ganglioside GD3.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900213-1

7 January 2021

Molecular specializations at nodes and paranodes in peripheral nerve

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900213-1

7 January 2021

Distinct immunoglobulin class and immunoglobulin G subclass patterns against ganglioside GQ1b in Miller Fisher syndrome following different types of infection

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900213-1

7 January 2021

Lipo-oligosaccharides of Campylobacter jejuni serotype O:10. Structures of core oligosaccharide regions from a bacterial isolate from a patient with the Miller-Fisher syndrome and from the serotype reference strain

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900213-1

7 January 2021

Functional rafts in cell membranes

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900213-1

7 January 2021

Cholinergic neuron-specific ganglioside GQ1b alpha a possible target molecule for serum IgM antibodies in some patients with sensory ataxia

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900213-1

7 January 2021

Ophthalmoplegic and lower cranial nerve variants merge into each other and into classical Guillain-Barré syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900213-1

7 January 2021

Gangliosides and synaptic transmission

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900213-1

7 January 2021

Fisher syndrome with tetraparesis and antibody to GQ1b: evidence for motor nerve terminal block

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900213-1

7 January 2021

Miller Fisher-Guillain-Barré overlap syndrome with enhancing lesions in the spinocerebellar tracts

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900213-1

7 January 2021

Gangliosides and bacterial toxins in Guillain-Barré syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900213-1

7 January 2021

Immunoglobulin subclass distribution and binding characteristics of anti-GQ1b antibodies in Miller Fisher syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900213-1

7 January 2021

Peripheral neuropathy associated with monoclonal IgM anti-Pr2 cold agglutinins

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900213-1

7 January 2021

Miller Fisher syndrome is associated with serum antibodies to GQ1b ganglioside

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900213-1

7 January 2021

Acute ataxic neuropathy with cross-reactive antibodies to GD1b and GD3 gangliosides

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900213-1

7 January 2021

A somatically mutated human antiganglioside IgM antibody that induces experimental neuropathy in mice is encoded by the variable region heavy chain gene, V1-18.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900213-1

7 January 2021

Miller Fisher syndrome with central involvement: successful treatment with plasmapheresis

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900213-1

7 January 2021

Successful plasmapheresis in Bickerstaff's brain stem encephalitis associated with anti-GQ1b antibody

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900213-1

7 January 2021

Molecular mimicry between gangliosides and lipopolysaccharides of Campylobacter jejuni isolated from patients with Guillain-Barré syndrome and Miller Fisher syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900213-1

7 January 2021

Acute relapsing sensory neuropathy associated with IgM antibody against B-series gangliosides containing a GalNAc beta 1-4(Gal3-2 alpha NeuAc8-2 alpha NeuAc)beta 1 configuration

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900213-1

7 January 2021

Frequent presence of anti-GQ1b antibody in Fisher's syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2899%2900213-1

7 January 2021

10.1016/S0165-5728(99)00213-1

Identifiers

DOI

1 reference

29 July 2017

1 reference